Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C068073 |
Am 580 |
Am 580 results in decreased expression of AGRN mRNA | decreases expression | 16982809
|
D000499 |
Allylamine |
Allylamine results in increased expression of AGRN mRNA | increases expression | 15910882
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of AGRN mRNA | affects expression | 16483693
|
C004541 |
biochanin A |
biochanin A results in decreased expression of AGRN mRNA | decreases expression | 12111696
|
D002166 |
Camptothecin |
Camptothecin results in increased expression of AGRN mRNA | increases expression | 17374387
|
D003630 |
Daunorubicin |
Daunorubicin results in increased expression of AGRN mRNA | increases expression | 17374387
|
C014347 |
decitabine |
[decitabine co-treated with vorinostat] affects the expression of AGRN mRNA | affects cotreatment|affects expression | 17330099
|
D005047 |
Etoposide |
Etoposide results in increased expression of AGRN mRNA | increases expression | 17374387
|
D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of AGRN mRNA | increases expression | 16807920
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of AGRN mRNA | decreases expression | 17426115
|
D011374 |
Progesterone |
Progesterone results in increased expression of AGRN protein | increases expression | 16777347
|
C089730 |
rosiglitazone |
rosiglitazone results in decreased expression of AGRN mRNA | decreases expression | 16982809
|
D012643 |
Selenium |
Selenium results in increased expression of AGRN mRNA | increases expression | 19244175
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of AGRN mRNA | increases expression | 17879257
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of AGRN mRNA | increases expression | 19101580
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of AGRN mRNA | decreases expression | 19244175
|
C111237 |
vorinostat |
[decitabine co-treated with vorinostat] affects the expression of AGRN mRNA | affects cotreatment|affects expression | 17330099
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.48 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.91 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.55 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.10 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.47 | 16434500 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.70 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.90 | 16712894 17306315 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
2.85 | 19621015 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.23 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.55 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.01 | 18940202 17688650 19232924 18316065 19460635 17507914 17157402 18558336 18396377 18985861 15238991 18775368 18177632 16609825 20603192 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.06 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.13 | 19483382 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.39 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
5.16 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.34 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.24 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.09 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
2.09 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.09 | 17614352 16175315 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
vorinostat |
2.09 | 16144943 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.92 | 16050911 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
1.98 | 16507464 17306315 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.78 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.78 | 18572023 |
MESH:D002386 |
Cataract |
|
Am 580 |
4.34 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
2.97 | 20056578 19524636 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.70 | 20734317 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.81 | 19176532 |
MESH:D003092 |
Colitis |
|
Am 580 |
9.91 | 17035595 |
MESH:D003092 |
Colitis |
|
Selenium |
9.91 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.33 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.71 | 8888407 17688650 16575769 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
2.71 | 19769572 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.41 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
4.28 | 17446233 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
2.93 | 12642470 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.48 | 17187935 |
MESH:D003967 |
Diarrhea |
|
vorinostat |
4.48 | 20479100 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
3.99 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
3.99 | 19641884 1733752 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.03 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.70 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.94 | 12083418 |
MESH:D004487 |
Edema |
|
rosiglitazone |
6.94 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.76 | 17692515 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.12 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.75 | 16134523 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.14 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.92 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.92 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.57 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.28 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.06 | 3659116 |
MESH:D005221 |
Fatigue |
|
vorinostat |
5.59 | 20479100 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.11 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
13.11 | 19196556 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.11 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.89 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.11 | 8888407 18558336 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.67 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
biochanin A |
4.45 | 16598420 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.47 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
2.98 | 16080930 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.91 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
6.91 | 17162251 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
2.98 | 18467677 16221962 19176532 19772884 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.69 | 16863852 16490937 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.55 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
7.59 | 16135485 18180244 15147373 16200630 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
7.59 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.97 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.86 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
3.90 | 12083418 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.16 | 20558911 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.39 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
6.86 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.86 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.41 | 15869954 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
5.41 | 12083418 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
10.96 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
10.96 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.46 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
7.46 | 16306350 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.15 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
6.15 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.87 | 16518626 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.06 | 18980019 19235587 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
3.98 | 17236224 18454857 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
marker/mechanism |
|
| 17330099 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.98 | 19387464 18704418 19010910 18206229 17679729 18460780 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.98 | 16294345 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.46 | 18055864 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.56 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
3.56 | 17347453 15980055 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
3.56 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.46 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
4.46 | 16712894 15276417 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.39 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
7.39 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.26 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.54 | 16712894 17306315 17077188 15276417 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
2.54 | 11062179 |
MESH:D008223 |
Lymphoma |
|
decitabine |
7.84 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
7.84 | 12854902 12556972 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
vorinostat |
5.67 | 20479100 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
10.02 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
10.02 | 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
10.02 | 15318939 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.44 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.44 | 16487513 19082730 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.78 | 15107826 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.36 | 17261469 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.17 | 18803445 18765137 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.33 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.49 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.01 | 8888407 |
OMIM:254300 |
MYASTHENIA, LIMB-GIRDLE, FAMILIAL |
marker/mechanism |
|
| |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.47 | 18608210 19010910 16882708 19157545 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.47 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.13 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.93 | 16411023 |
MESH:D009325 |
Nausea |
|
vorinostat |
5.52 | 20479100 |
MESH:D009369 |
Neoplasms |
|
decitabine |
8.22 | 19470736 17925555 19116145 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.22 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.22 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.65 | 20056578 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.29 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.29 | 8888407 16359493 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.81 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
7.92 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
7.92 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.92 | 15276417 17306315 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.65 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
5.65 | 19003803 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.89 | 15087411 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Daunorubicin |
4.76 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
3.82 | 20603192 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.71 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
biochanin A |
1.93 | 12111696 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
1.93 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.93 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
1.93 | 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
vorinostat |
1.93 | 17218635 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.54 | 11422049 12752131 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.38 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
10.92 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.92 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.85 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
4.69 | 14601052 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.72 | 14763951 11044598 16876388 3137016 1511512 15475178 11738929 17978042 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.44 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.69 | 18572023 19524636 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.27 | 15862959 16503802 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.49 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.49 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.54 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.50 | 16517955 |
MESH:D024801 |
Tauopathies |
|
Camptothecin |
12.19 | 16930453 |
MESH:D024801 |
Tauopathies |
|
Daunorubicin |
12.19 | 16930453 |
MESH:D013921 |
Thrombocytopenia |
|
vorinostat |
4.95 | 20479100 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.31 | 17967635 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.23 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.51 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.22 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.22 | 17306315 16712894 16452187 11723127 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.63 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.75 | 11813266 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.91 | 17785578 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.42 | 17056641 |